Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $570M invested in Infinity Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 21 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 29
3.84% more ownership
Funds ownership: 95.13% → 98.97% (+3.8%)
6% less funds holding
Funds holding: 104 → 98 (-6)
10% less capital invested
Capital invested by funds: $634M → $570M (-$63.5M)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
51% less call options, than puts
Call options by funds: $4.43M | Put options by funds: $9.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$16.9M |
| 2 |
HM
HealthCor Management
New York
|
+$14.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.39M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$8.37M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$9.96M |
| 2 |
VAM
Visium Asset Management
New York
|
-$6.73M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.18M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.95M |
| 5 |
PA
Perceptive Advisors
New York
|
-$4.83M |
INFI Hedge Fund Activity: Q1 2014 in Review
98 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2014, worth a combined $570M — down 10% from $634M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of INFI and 16 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 37 added.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $16.9M. The largest seller was QVT Financial, exiting entirely with an estimated $9.96M sold.
- 98 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2014, down from 104 in Q4 2013.
- Funds reported $570M of Infinity Pharmaceuticals, Inc. stock for Q1 2014, down 10% quarter-over-quarter.
- 16 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2014 and 21 closed out, a net change of -5 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2014 was Consonance Capital Management, an estimated $16.9M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q1 2014 was QVT Financial, an estimated $9.96M sold.
Based on aggregated 13F filings for Q1 2014.